Compare STBA & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STBA | AZTA |
|---|---|---|
| Founded | 1902 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 1995 |
| Metric | STBA | AZTA |
|---|---|---|
| Price | $40.12 | $35.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $41.25 | ★ $43.60 |
| AVG Volume (30 Days) | 210.7K | ★ 667.4K |
| Earning Date | 10-23-2025 | 11-21-2025 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.46 | N/A |
| Revenue | $391,893,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $7.40 | $6.13 |
| Revenue Next Year | $4.94 | $5.02 |
| P/E Ratio | ★ $11.60 | $66.13 |
| Revenue Growth | ★ 1.21 | N/A |
| 52 Week Low | $30.84 | $23.91 |
| 52 Week High | $43.67 | $55.64 |
| Indicator | STBA | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 59.20 |
| Support Level | $38.27 | $34.34 |
| Resistance Level | $40.70 | $38.20 |
| Average True Range (ATR) | 1.01 | 1.48 |
| MACD | 0.08 | 0.21 |
| Stochastic Oscillator | 77.50 | 65.42 |
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.